Novel M-Component Based Biomarkers in Waldenström's Macroglobulinemia
- 1 February 2011
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 164-167
- https://doi.org/10.3816/clml.2011.n.039
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Quantification of Serum IgMκ and IgMλ In Patients with Waldenstrom's Macroglobulinemia (WM) at Diagnosis and During Disease Course; Clinical CorrelationsBlood, 2010
- The Role of Serum Immunoglobulin Free Light Chain In Response and Progression In Waldenstrom MacroglobulinemiaBlood, 2010
- Heavy/Light-Chain Analysis of Monoclonal GammopathiesClinical Chemistry, 2009
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersLeukemia, 2008
- Serum-free light chain elevation is associated with a shorter time to treatment in Waldenstrom's macroglobulinemiaHaematologica, 2008
- Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemiaLeukemia & Lymphoma, 2008
- Serum free light chains for monitoring multiple myelomaBritish Journal of Haematology, 2004
- Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and UrineClinical Chemistry, 2001